Quick Search 
Drugs of Today
Register or sign in

Volume 56, Issue 1, January 2020, Pages 5-107
 Galcanezumab: a humanized monoclonal antibody for the prevention of migraine and cluster headache.
Ossipov, M.H., Raffa, R.B., Pergolizzi, Jr., J.V.
Drugs Today 2020, 56(1): 5
Summary | Full Text: PDF 
 Ivosidenib to treat adult patients with relapsed or refractory acute myeloid leukemia.
Pasquier, F., Lecuit, M., Broutin, S., Saada, V., Jeanson, A., Penard-Lacronique, V., de Botton, S.
Drugs Today 2020, 56(1): 21
Summary | Full Text: PDF 
 Siponimod to treat secondary progressive multiple sclerosis.
Gajofatto, A., Turatti, M.
Drugs Today 2020, 56(1): 37
Summary | Full Text: PDF 
 The year's new drugs and biologics 2019.
Graul, A.I., Pina, P., Tracy, M., Sorbera, L.
Drugs Today 2020, 56(1): 47
Summary | Full Text: PDF 
 New product intros [betibeglogene darolentivec, evocalcet (new indication), fexinidazole, GV-971, lascufloxacin hydrochloride, luspatercept-aamt, semaglutide (new formulation), trastuzumab deruxtecan (fam-trastuzumab deruxtecan-nxki), voxelotor].
Drugs Today 2020, 56(1): 105
Full Text: PDF 

© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy